Skip to content
MedsAcross

Brand family

Qsymia

United States
Presentations
4
Markets
1

Qsymia is a brand of Phentermine and Topiramate marketed by Vivus, with 4 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.

Active ingredient (INN)
Phentermine and Topiramate
Brand owner
Vivus
Registered in
United States
Strengths and forms
11.25 mg/69 mg extended-release capsule, 15 mg/92 mg extended-release capsule, 3.75 mg/23 mg extended-release capsule, 7.5 mg/46 mg extended-release capsule

All presentations

MedicineManufacturerRegisterAvailability
Qsymia 11.25 mg/69 mg extended-release capsuleOralVivusUS FDAAvailable on request
Qsymia 15 mg/92 mg extended-release capsuleOralVivusUS FDAAvailable on request
Qsymia 3.75 mg/23 mg extended-release capsuleOralVivusUS FDAAvailable on request
Qsymia 7.5 mg/46 mg extended-release capsuleOralVivusUS FDAAvailable on request

Brand names and trademarks belong to their owners and are used only to identify products.

Request Qsymia

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.